(Q53238194)
Statements
Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease. (English)
Weiner HL
Lemere CA
Maron R
Spooner ET
Grenfell TJ
Mori C
Issazadeh S
Hancock WW
Selkoe DJ
1 October 2000
48
4
567-579